McDermott + Bull has successfully placed Lisa Downey as Chief Executive Officer at DrugBank. In this role, Lisa will lead the company’s next phase of growth, deepening its impact across pharmaceutical R&D and AI-driven drug discovery while scaling commercial...
In today’s employment landscape, innovation alone isn’t enough to win the race for top talent. The most capable executives and emerging leaders aren’t just looking for another job — they’re searching for a mission worth committing to. They want to see substance behind...
McDermott + Bull Partner Ken Dropiewski sits down with Kate Garrett of Sonder Capital to explore her journey, the firm’s investment philosophy, and the current MedTech landscape. Kate shares how Sonder identifies bold technologies that can redefine patient care, why...
McDermott + Bull has successfully placed Julianna Uresch as Senior Director of Upstream Marketing at Vista.ai. In this role, Julianna will lead product strategy and market development for Vista.ai’s AI-powered MRI platform, Vista Cardiac, and future applications...
McDermott + Bull Partner Ken Dropiewski sits down with Founding Partner, Tasneem Dohadwala from Excelestar Ventures to explore essential topics for investors in the MedTech space. In this wide-ranging interview, Tasneem shares Excelestar’s investment focus, what they...
McDermott + Bull Partner Ken Dropiewski sits down with KCK Group’s Senior Managing Director Greg Garfield to explore essential topics for investors in the MedTech space. Greg provides an inside look at KCK Group’s typical investment and team structure, as...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policy
